Pelthos Therapeutics Inc. (PTHS) — Financial Flexibility Index

Latest as of December 2025: -0.07x

Pelthos Therapeutics Inc. (PTHS) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-6.15 Million (operating CF $-6.25 Million minus capex $99.00K) represents 0% of total liabilities ($91.52 Million). Also explore Pelthos Therapeutics Inc. net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.07x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-6.15 Million
Operating CF − Capex

Total Liabilities

$91.52 Million
USD

Capital Expenditures

$99.00K
USD

Pelthos Therapeutics Inc. Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for Pelthos Therapeutics Inc. across 5 annual periods. See Pelthos Therapeutics Inc. net asset quality index to measure how much of total assets are equity-financed.

Annual Financial Flexibility Index for Pelthos Therapeutics Inc. (2021–2025)

Year-by-year free cash flow to debt coverage for Pelthos Therapeutics Inc.. For the full company profile including market capitalisation, see market value of Pelthos Therapeutics Inc..

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.25x $-22.49 Million $-22.59 Million $91.52 Million ▲ +82.7%
2024 -1.42x $-5.79 Million $-5.79 Million $4.08 Million ▼ -845.8%
2023 -0.15x $-981.03K $-981.03K $6.54 Million ▲ +64.0%
2022 -0.42x $-1.57 Million $-1.57 Million $3.76 Million ▲ +3.8%
2021 -0.43x $-1.59 Million $-1.59 Million $3.68 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities